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a EgyptBackground: Right ventricular (RV) dysfunction is associated with poor prognosis in patients with heart failure (HF).
Echocardiographic assessment of RV systolic function is challenging. The ability to visualize the right atrium (RA)
allows a quantitative, highly reproducible assessment of RA volume.
Objective: The aim is to study the relationship between the right atrial volume index (RAVI) and prognosis in
patients with chronic systolic HF.
Methods: 120 patients with chronic systolic HF and left ventricular ejection fraction (LVEF) <40% were enrolled.
The RA volume was calculated by Simpson’s method using single-plane RA area and indexed to body surface area
(RAVI). RV systolic assessment was done using the RV fractional area change (RVFAC), and peak systolic velocity
(Satri) using tissue Doppler imaging at the tricuspid annulus. The primary endpoint was death, urgent transplanta-
tion, or acute HF episode requiring hospital admission during a follow-up of 1 year.
Results: Follow up was complete for 117 of 120 patients. Fifty-two patients reached the primary endpoint. The
mean RAVI was higher in patients with adverse events (45.5 ± 15 ml/m2 versus 25.2 ± 11 ml/m2, p < 0.001), and
increased with worsening LVEF, RVFAC, Satri (Spearman’s r = 0.46, r = 0.45, r = 0.59, p < 0.001 for all). RAVI
was not correlated with estimates of RV diastolic dysfunction. The cut-off threshold for RAVI to predict the primary
endpoint using receiver-operating characteristic curve was 29 ml/m2 (area under the curve was 0.89%, 95% confidence
interval: 0.82–0.95) with a sensitivity of 92%, and a specificity of 75%. NYHA > 2 (OR = 2.1, p < 0.01), and RAVI
(OR = 1.6, p < 0.05) were found to be independent predictors of adverse outcome.
Conclusion: In patients with chronic systolic HF, RAVI is an independent predictor of adverse outcome with a
threshold value of 29 ml/m2.
 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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Abbreviations
Aa peak late diastolic TDI velocity
ACE angiotensin converting enzyme
A-wave peak late diastolic filling velocity
CABG coronary artery bypass grafting
CI 95% confidence interval
DT early diastolic deceleration time
Ea peak early diastolic TDI velocity
E-wave peak early diastolic filling velocity
HF heart failure
IVC inferior vena cava
LVEF left ventricular ejection fraction
NYHA New York Heart Association
PCI percutaneous coronary intervention
RA right atrium
RAVI right atrial volume index
ROC receiver operator characteristic
RV right ventricular
RVFAC right ventricular fractional area change
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Patients with congestive heart failure (HF) stillhave a poor prognosis, even after recent ad-
vances in therapy [1,2]. It is, therefore, important
to establish a reliable means of identifying those
patients at higher risk. Right ventricular (RV)
systolic dysfunction is associated with poor long-
term prognosis [3,4]. However, precise echocar-
diographic assessment of RV systolic function is
challenging, primarily because the morphology
of RV is complicated.
The ability to visualize the right atrium (RA)
allows a quantitative, highly reproducible assess-
ment of the RA volume that can be indexed to
the body surface area [5,6]. However, there have
been no many studies correlating RA volume
and prognosis in patients with chronic HF [6].Sa peak systolic TDI velocity
Satri peak tissue Doppler systolic velocity at the
tricuspid annulus
sPAP systolic pulmonary artery systolic pressure
TDI tissue Doppler imaging
Vmax peak velocityObjective
Is to determine the relationship between the
right atrial volume index and prognosis in pa-
tients with chronic systolic heart failure.Methodology
Patient population
We enrolled consecutive patients with chronic
heart failure evaluated at a tertiary cardiac center
from 2009 to 2011. Inclusion criteria were age
>18 years, symptomatic heart failure (New York
Heart Association class II-IV), and left ventricular
ejection fraction (LVEF) <40%. Exclusion criteria
were mitral stenosis, mitral valve surgery, severe
mitral regurgitation (>grade 3), severe aortic ste-
nosis (peak velocity >4 m/s), malignancy, and
severe renal failure requiring dialysis.
The study was approved by the medical ethics
committee of our institution. The study protocol
was designed in accordance with The Code of Ethics
of the World Medical Association (Declaration of
Helsinki) for experiments involving humans.
All patients gave informed consent before the
procedure.
Echocardiographic examination
Comprehensive transthoracic echocardiography
was performed using an Aloka alpha 5 echocardi-
ography machine (Hitachi Aloka Medical, Ltd.,
manufactured in Tokyo, Japan) equipped with tis-
sue Doppler imaging (TDI) technology. Two-
dimensional, M-mode, Doppler echocardiography
measurements and quantification were performed
according to recommendations of the American
Society of Echocardiography [7,8]. Right atrial vol-ume was calculated using the Simpson’s method
from the apical four-chamber view at end systole
[5,6]. The right atrial volume index (RAVI) was de-
rived by dividing the volume by body surface
area, which was calculated using the Du Bois
and Du Bois formula [9]. Continuous Doppler
echocardiography was used to measure pulmon-
ary artery and aortic velocities, tricuspid regurgi-
tation velocity, and mitral regurgitation velocity.
Pulsed Doppler echocardiography for the assess-
ment of the standard diastolic filling velocities of
both ventricles was performed using the apical
four-chamber view. Thus, the peak early diastolic
filling velocity (E-wave), early diastolic decelera-
tion time (DT), and peak late diastolic filling veloc-
ity (A-wave) were recorded. For the right ventricle
2D and TDI measurements, care was taken to ob-
tain an ultrasound beam parallel to the tricuspid
annulus motion. The RV endocardium was traced
manually in systole and diastole. The RV frac-
tional area change (RVFAC) was calculated using
the formula: (end-diastolic area – end-systolic
area)/end-diastolic area. Tricuspid annular TDI
was acquired in the apical 4-chamber view. Peak
systolic (Sa), early diastolic (Ea), and late diastolic
(Aa) velocities of the tricuspid annulus were mea-
sured as recommended previously (sample TDI
volume less than 5 mL and an angle between the
TDI sample volume and the longitudinal myocar-
dial wall vector less than 20) [10]. The systolic
pulmonary artery systolic pressure (sPAP) was
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right ventricle and the right atrium using the peak
velocity (Vmax) of the tricuspid regurgitation
(sPAP = 4(Vmax)
2 + right atrial pressure). The right
atrial pressure was based on both the size of the
inferior vena cava (IVC) and the change in diame-
ter of this vessel during respiration [11]. Briefly,
IVC diameter 62.1 cm that collapsed >50% with
a sniff indicated normal RA pressure of 3 mmHg,
whereas IVC diameter >2.1 cm that collapsed
<50% with a sniff suggested high RA pressure of
15 mmHg. In scenarios in which IVC diameter
and collapse did not fit this paradigm, an interme-
diate value of 8 mmHg was used. Pulsed-wave
Doppler recording of the hepatic vein flow was
done using a sample volume placed in the hepatic
vein 1 cm proximal to junction of IVC and hepatic
veins. Hepatic vein systolic/diastolic (S/D) ratio
was calculated. Valvular regurgitation was graded
according to guidelines of the American Society of
Echocardiography [12]. All parameters were aver-
aged over three heart cycles (five cycles for
arrhythmia).
Clinical follow-up and endpoint definition
Clinical follow-up was for 1 year. The vital status
of each patient was confirmed by a review ofTable 1. Baseline demographic and clinical characteristics of the p
Variables Event
Yes (n = 52)
Age (years) 54.5 ± 14.8
Body surface area (m2) 1.81 ± 0.4
Systolic BP (mmHg) 120 ± 11
Diastolic BP (mmHg) 79 ± 4
Gender
Male 42(80.8%)
Female 10(19.2%)
Etiology of HF
Ischemic 24(46.2%)
Non-ischemic 28(53.8%)
NYHA class III–IV 50 (96.2%)
Heart rate 87 ± 5
Hypertension 10(19.2%)
Smoking 14(26.9%)
Diabetes 25(48.1%)
Previous myocardial infarction 19 (36.5%)
Previous of HF admission 36(69.2%)
Previous PCI 3(5.8%)
Previous CABG 3(5.8%)
B-blockers 36(69.2%)
ACE-inhibitors 48(92.3%)
Diuretics 51(98.1%)
Digitalis 31(59.6%)
Spironolactone 36(69.2%)
Data are expressed as a mean ± standard deviation or a number (percent). N
New York heart association, PCI = percutaneous coronary intervention, C
enzyme.medical records or by telephone contact (family
and/or patient). The primary endpoint was the
combined risk of death or urgent heart transplan-
tation or hospitalization for acute HF episode.
Hospitalization for HF was defined as an admis-
sion for worsening HF in which intravenous ther-
apy for HF was needed. The first event was
considered for each patient.
Statistical analysis
The data were statistically analyzed using the
Statistical Package for Social Sciences (SPSS)
software version 17 (SPSS Inc., Chicago, IL, USA).
Continuous variables were presented as mean ±
standard deviation and categorical variables as
absolute numbers (percentages). Categorical vari-
ables were compared by Chi-square test. Continu-
ous normally distributed variables were compared
by two-tailed t-test. Correlations between RAVI
and echocardiographic variables were tested with
Spearman’s r. The optimal cut-off for the predic-
tion of primary event was determined by a recei-
ver-operator characteristic (ROC) curve. ROC
analysis was used to determine the sensitivity
and specificity of RAVI in predicting the primary
endpoint. Kaplan–Meier curves were constructed
to show event-free survival according to time.atients according to the incidence of primary outcome events.
P value
No (n = 65)
54 ± 14 NS
1.85 ± 0.2 NS
123 ± 12 NS
80.3 ± 6 NS
45(69.2%) NS
20(30.8%)
26(40%) NS
39(60%)
39(60%) <0.001
93 ± 20 NS
14(21.9%) NS
13(20%) NS
18(27.7%) <0.05
19(29.2% NS
21(32.3%) <0.001
2(3.1%) NS
5(7.7%) NS
52(80%) NS
65(100%) NS
57(87.7%) <0.05
27(41.5%) <0.05
32(49.2%) <0.05
S = non-significant, BP = blood pressure, HF = heart failure, NYHA = -
ABG = coronary artery bypass surgery, ACE = angiotensin converting
Table 2. Echocardiographic parameters of the patients according to the incidence of primary outcome events.
Variables Event P value
Yes (n = 52) No (n = 65)
Left atrial diameter (mm) 48 ± 7 43.4 ± 3.9 0.0001
LV parameters
LV end-diastolic dimension index (mm/m2) 36.7 ± 5 35.8 ± 5 NS
LV end-systolic dimension index (mm/m2) 32 ± 5 30.2 ± 5 NS
LV ejection fraction (%) 24.5 ± 5.4 31.4 ± 4.9 0.0001
Mitral early/late flow velocity 3.5 ± 1.4 2.5 ± 1.7 0.001
Mitral deceleration time (ms) 130 ± 27 143.5 ± 39 0.04
Mitral TD systolic velocity (cm/s) 4.5 ± 1.4 5.2 ± 1.4 0.007
Mitral TD early diastolic velocity (cm/s) 7.1 ± 2.5 7.6 ± 3.3 NS
Mitral TD late diastolic velocity (cm/s) 3.4 ± 1.2 4.8 ± 2.2 0.001
Right atrial volume index (ml/ m2) 45.5 ± 15.7 25.2 ± 11.6 0.0001
RV parameters
RV end-diastolic area (cm2) 20.3 ± 6 15.9 ± 5 0.001
RV end-systolic area (cm2) 14.5 ± 5 9.9 ± 4 0.001
RV fractional area change (%) 30.1 ± 11 43.7 ± 6 0.025
Tricuspid early/late flow velocity 1.2 ± 0.6 0.90 ± 0.4 0.03
Tricuspid TD systolic velocity (cm/s) 10.3 ± 1.7 12.9 ± 1.7 <0.001
Tricuspid TD early diastolic velocity (cm/s) 10.5 ± 5 10.7 ± 3 NS
Tricuspid TD late diastolic velocity (cm/s) 9.9 ± 4 12.6 ± 5 <0.05
Pulmonary artery systolic pressure (mmHg) 51 ± 13 39 ± 10.5 0.001
Hepatic vein systolic/diastolic ratio 1.1 ± 0.5 1.4 ± 0.7 0.086
NS = non-significant, LV = left ventricle. TD = tissue Doppler. Data are expressed as a mean ± standard deviation or a number (percent).
Table 3. Relation of all predictors to the event by logistic regression analysis.
Variables Beta coefficient Odd’s (95% CI) P value
NYHA class > 2 0.98 2.1(0.9–8.5) <0.001
RAVIP 29 ml/m2 0.37 1.6(0.4–7) <0.05
Satri < 10 cm/s 0.30 1.5(0.2–6.95) <0.05
CI: confidence interval, NYHA:New York heart association, RAVI: right atrial volume index, Satri = Tricuspid TD
systolic velocity.
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nique was used to find out the significant indepen-
dent predictors of the primary endpoint. A p
value 6 0.05 (2-tailed) was considered significant
and a p value 6 0.01 was considered highly signif-
icant. Reproducibility of RAVI (intra-observer var-
iability) was assessed by coefficient of variation for
repeated measures in a random sample of 30 pa-
tients and was 6%.Results
The study included 120 patients with chronic
systolic HF and left ventricular ejection fraction
(LVEF) <40%. Follow up was complete for 117 of
120 patients. Fifty-two (44.4%) of 117 patients
reached the primary endpoint (7 deaths, and 45
hospital admission for HF). The baseline demo-
graphic and clinical characteristics of the studied
patients are detailed in Table 1. Patients with the
primary outcome events had higher incidence ofadvanced NYHA class, diabetes, and past heart
failure admission. They also used more diuretics,
spironolactone, and digitalis.
Echocardiographic variables in patients with
and without an event are listed in Table 2. For left
sided parameters, the group with outcome events
showed lower LVEF, mitral DT, mitral Sa, and mi-
tral Aa, together with higher LA diameter, and mi-
tral E/A ratio. For right-sided parameters, the
group with primary endpoint events showed
higher RAVI, higher RV area, higher sPAP, lower
RVFAC, lower tricuspid Sa, and lower tricuspid
Aa.
In multivariate analysis, RAVI remained an
independent predictor of adverse outcomes
using logistic regression analysis (odd’s ratio of
1.6, 95% confidence interval: 0.4–7, p value <0.05,
Table 3).
The overall mean RAVI in the study population
was 34.0 ± 16.7 ml/m2. The mean RAVI was higher
in men than in women (35.8 ± 17.5 vs. 28.9 ± 13.1,
Figure 1. The cut-off value for RAVI using ROC curve was 29 ml/m2,
AUC (95% CI) = 0.89 (0.82–0.95).
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with an event than in those without an event
(45.5 ± 15.7 vs. 25.2 ± 11.6, p = 0.0001). The mean
RAVI increased with worsening Satri, NYHA class,
LVEF, RVFAC (Spearman’s r = 0.59, r = 0.55,
r = 0.46, r = 0.45, p < 0.001 for all). RAVI was
not correlated with estimates of RV diastolic
dysfunction (tricuspid flow E/A ratio, or hepatic
vein S/D ratio).
The cut-off threshold for RAVI to predict the
primary endpoint using receiver-operating
characteristic curve was 29 ml/m2 (area under
the curve was 0.89, 95% confidence interval: 0.82–
0.95) with a sensitivity of 92%, and a specificity
of 75% (Fig. 1). Kaplan–Meier event-free survival
curves for RAVIP 29 ml/m2 (optimal cut-off valueFigure 2. Kaplan–Meier curves for RAVIP 29 ml/m2 and event-freedetermined using receiver-operating characteris-
tic analysis) are shown in Fig. 2. In the subgroup
with RAVIP 29 ml/m2, 46 out of 64 patients had
an event (71.9%). In the subgroup with RA-
VI < 29 ml/m2, only 6 out of 53 patients had an
event (11.3%).Discussion
The present study shows that RAVI is an inde-
pendent predictor of outcome (death, urgent heart
transplantation, or hospitalization for acute HF
episode) in patients with chronic systolic HF with
reduced LVEF, when other important clinical and
echocardiographic markers such as NYHA, LVEF,
and Satri are considered. This finding is important
as it might help to identify the HF patient with
poor prognosis.
Right atrial volume index and prognosis in heart
failure
Right ventricular (RV) systolic dysfunction is
associated with poor long-term prognosis in
patients with HF [3,4]. Pulmonary artery pressure
and thermodilution-derived RV ejection fraction
were found to be independent predictors of ad-
verse outcome on Cox multivariate survival analy-
sis [3]. However, precise echocardiographic
assessment of RV systolic function is challenging,
primarily because the morphology of RV is com-
plicated. The ability to visualize the RA allows a
quantitative, highly reproducible assessment of
the RAVI [5,6]. In the present study, RAVI re-
mained an independent predictor of outcome
even when RV echocardiographic markers such
as RVFAC, Satri, tricuspid E/A ratio, and hepatic
vein S/D ratio are considered.survival. Log Rrank (Mantel–Cox) between both lines is 0.009.
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2014;26:73–79Sallach et al. showed that RAVI is an indepen-
dent predictor of cardiovascular events in patients
with chronic stable heart failure [6]. RAVI re-
mained an independent predictor of poor out-
comes after adjusting for age, brain naturetic
peptide, LVEF, RV systolic dysfunction stage,
and tricuspid E/Ea ratio (p = 0.005) [6]. In ROC
analysis, RAVIP 30.6 ml/m2 (optimal ROC cutoff)
had a 78% sensitivity and a 77% specificity
(p < 0.0001) for predicting RV systolic dysfunction
stage P3; and RAVIP 41.6 ml/m2 (optimal ROC
cutoff) had a 68% sensitivity and a 92% specificity
(p < 0.0004) for predicting NYHA functional class
P3 [6]. D’Andrea et al. demonstrated that a right
atrial area >16 cm2 had 87.1% sensitivity and
95.4% specificity in predicting a negative response
to cardiac resynchronization therapy in patients
with dilated cardiomyopathy [13].Right atrial volume index and right ventricular
functions
The present study showed a good correlation
between RAVI and worsening systolic right ven-
tricular parameters (Satri, and RVFAC). Similar
findings were reported in previous studies [6,14].
RAVI showed good correlation with RV systolic
dysfunction stage, and tricuspid annular Sa
(Spearman’s r = 0.61, and 0.34, respectively, p =
0.0001 for both) [6]. Another report demonstrated
that RAVI showed good correlation with RV end-
systolic diameter (r = 0.484, p = 0.002), and tricus-
pid annular plane systolic excursion (r = 0.47,
p = 0.001) [14].
In the present study, RAVI was not correlated
with estimates of RV diastolic dysfunction (tricus-
pid flow E/A ratio, or hepatic vein S/D ratio). This
finding was consistent with findings of Sallach
et al. [6]. They demonstrated that RAVI showed
only a modest correlation with tricuspid flow
E/A ratio, or hepatic vein S/D ratio, and no corre-
lation with the tricuspid E/Ea ratio [6]. This sug-
gests that RAVI may be reflective of the
chronicity of RV diastolic function over time (sim-
ilar to left atrial volume index) rather than a mea-
sure of instantaneous diastolic function [6]. This is
also emphasizes the complexity of measuring
right-sided diastolic function and the poor corre-
lation of right atrial volume to RV filling pressure
due to the additional effect of RA stiffness [15].
RV impairment secondary to LV failure usually
initiates due to pressure overload, which is trans-
lated to tricuspid regurgitation, and evolves to
right ventricular and right atrial dilatation [16].
Right atrial dilatation is usually observed at an ad-
vanced stage of pressure and volume overload.Thus, it may reflect a more severe clinical presen-
tation in patients with heart failure and reduced
LVEF.
Limitations of the study
The population studied was relatively small, but
despite the sample size, there was a high event
rate (44%). Therefore, we were able to reach sev-
eral significant conclusions. The RA volumes were
calculated using Simpson’s method from only one
view (the apical 4-chamber). This view places the
right atrium in the far field; therefore, diminishing
lateral resolution and adversely affecting visuali-
zation of right atrial endocardium. Finally the
present study did not include biological markers
for adverse outcome in heart failure such as brain
naturetic peptide, but this would have increased
the cost of the present study.Conclusion and recommendations
In patients with chronic systolic heart failure
and reduced LV ejection fraction, RAVI is an inde-
pendent predictor of adverse outcome with a
threshold value of 29 ml/m2.
In view of the small sample size included in this
report, larger clinical studies are needed to con-
firm these observations.Funding
The study was supported by our institution.Appendix A. Supplementary data
Supplementary data associated with this article
can be found, in the online version, at http://dx.
doi.org/10.1016/j.jsha.2013.09.002.
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